166 related articles for article (PubMed ID: 223499)
1. In vitro system for studying the efficacy of antiviral agents in preventing the reactivation of latent herpes simplex virus.
Wohlenberg C; Openshaw H; Notkins AL
Antimicrob Agents Chemother; 1979 Apr; 15(4):625-7. PubMed ID: 223499
[TBL] [Abstract][Full Text] [Related]
2. Effect of acyclovir, bromovinyldeoxyuridine, vidarabine, and L-lysine on latent ganglionic herpes simplex virus in vitro.
Park NH; Pavan-Langston D; Declercq E
Am J Med; 1982 Jul; 73(1A):151-4. PubMed ID: 6285706
[TBL] [Abstract][Full Text] [Related]
3. Treatment of experimental latent herpes simplex virus infections with acyclovir and other antiviral compounds.
Klein RJ
Am J Med; 1982 Jul; 73(1A):138-42. PubMed ID: 6285703
[TBL] [Abstract][Full Text] [Related]
4. Effect of acyclovir on latent herpes simplex virus infections in trigeminal ganglia of mice.
Klein RJ; DeStefano E; Friedman-Kien AE; Brady E
Antimicrob Agents Chemother; 1981 May; 19(5):937-9. PubMed ID: 6271054
[TBL] [Abstract][Full Text] [Related]
5. Acute and latent infection of sensory ganglia with herpes simplex virus: immune control and virus reactivation.
Openshaw H; Asher LV; Wohlenberg C; Sekizawa T; Notkins AL
J Gen Virol; 1979 Jul; 44(1):205-15. PubMed ID: 227991
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of phosphonoacetic acid on herpes simplex virus infection of sensory ganglia.
Wohlenberg CR; Walz MA; Notkins AL
Infect Immun; 1976 May; 13(5):1519-21. PubMed ID: 178609
[TBL] [Abstract][Full Text] [Related]
7. Effect of eight antiviral drugs on the reactivation of herpes simplex virus in explant cultures of latently infected mouse trigeminal ganglia.
Klein RJ; Friedman-Kien AE
J Invest Dermatol; 1984 Nov; 83(5):344-6. PubMed ID: 6208291
[TBL] [Abstract][Full Text] [Related]
8. Experimental skin infection with an acyclovir resistant herpes simplex virus mutant: response to antiviral treatment and protection against reinfection.
Klein RJ; DeStefano E; Brady E; Friedman-Kien AE
Arch Virol; 1980; 65(3-4):237-46. PubMed ID: 6251784
[TBL] [Abstract][Full Text] [Related]
9. In vitro effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, 5'-amino-5-iodo-2',5'-dideoxyuridine and 2-deoxy-D-glucose on latent ganglionic herpes simplex virus infection.
Pavan-Langston D; Park NH; De Clercq E
Antiviral Res; 1984 Apr; 4(1-2):53-61. PubMed ID: 6331305
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus type 2 latency in the footpad of mice: effect of acycloguanosine on the recovery of virus.
Al-Saadi SA; Gross P; Wildy P
J Gen Virol; 1988 Feb; 69 ( Pt 2)():433-8. PubMed ID: 2828517
[TBL] [Abstract][Full Text] [Related]
11. Orofacial herpes simplex virus infection in hairless mice: latent virus in trigeminal ganglia after topical antiviral treatment.
Klein RJ; Friedman-Kien AE; Yellin PB
Infect Immun; 1978 Apr; 20(1):130-5. PubMed ID: 208970
[TBL] [Abstract][Full Text] [Related]
12. Differential sensitivity of herpes simplex virus types 1 and 2 to human interferon: antiviral effects of interferon plus 9-beta-D-arabinofuranosyladenine.
Lerner AM; Bailey EJ
J Infect Dis; 1976 Oct; 134(4):400-4. PubMed ID: 185303
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the in vitro-reactivation of latent herpes simplex virus infection in spinal ganglia: comparison of various immune factors. Brief report.
von Rheinbaben F; Schneweis KE
Arch Virol; 1986; 87(3-4):315-9. PubMed ID: 2418807
[TBL] [Abstract][Full Text] [Related]
14. Latent herpes simplex virus in ganglia of mice after primary infection and reinoculation at a distant site.
Klein RJ; Friedman-Kien AE; Brady E
Arch Virol; 1978; 57(2):161-6. PubMed ID: 208489
[TBL] [Abstract][Full Text] [Related]
15. Heterotypic and homotypic re-inoculation of mice already latently infected with herpes simplex virus type 1.
Yirrell DL; Blyth WA; Hill TJ; Rogers CE
Arch Virol; 1990; 110(1-2):25-36. PubMed ID: 2155598
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and genetic analysis of acyclovir-resistant mutants of herpes simplex virus type 1.
Coen DM; Schaffer PA; Furman PA; Keller PM; St Clair MH
Am J Med; 1982 Jul; 73(1A):351-60. PubMed ID: 6285722
[No Abstract] [Full Text] [Related]
17. An acyclovir-resistant strain of herpes simplex virus type 2 which is highly virulent for mice.
Sakuma S; Yamamoto M; Kumano Y; Mori R
Arch Virol; 1988; 101(3-4):169-82. PubMed ID: 2845890
[TBL] [Abstract][Full Text] [Related]
18. Immune response and latent infection after topical treatment of herpes simplex virus infection in hairless mice.
Klein RJ; Friedman-Kien AE; Fondak AA; Buimovici-Klein E
Infect Immun; 1977 Jun; 16(3):842-8. PubMed ID: 197008
[TBL] [Abstract][Full Text] [Related]
19. Persistent reactivable latent herpes simplex virus infection in trigeminal ganglia of mice treated with antiviral drugs.
Svennerholm B; Vahlne A; Lycke E
Arch Virol; 1981; 69(1):43-8. PubMed ID: 6271097
[TBL] [Abstract][Full Text] [Related]
20. Ocular herpes simplex virus infections: reduced sensitivity to acyclovir in primary disease.
Charles SJ; Gray JJ
Br J Ophthalmol; 1990 May; 74(5):286-8. PubMed ID: 2162190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
